Topical JAK Inhibitor Active in Atopic Dermatitis

(MedPage Today) — Significant improvement in multiple endpoints after 4 weeks with ruxolitinib cream Source: Dermatology

(MedPage Today) — Significant improvement in multiple endpoints after 4 weeks with ruxolitinib cream
Source: Dermatology

Leave a Reply